Quick Heal Technologies Ltd
Software & Services | Small Cap
Quick Heal Technologies exhibits a mixed financial performance. The company demonstrates strong solvency due to its zero debt levels, but this is offset by poor coverage ratios. Growth is a mixed bag, with significant revenue and asset declines balanced by strong operating profit, EPS, and net income growth. Profitability metrics, such as gross profit margin, ROCE, ROE, operating margin, and net margin, are very strong, yet efficiency is significantly hampered by poor asset and capital turnover. Liquidity is also a concern, with low current, cash, and operating cash flow ratios. The IT sector's competitive landscape requires constant innovation and adaptation, and Quick Heal's ability to balance growth with efficiency and liquidity will be critical for its future success. The company's poor performance in some areas raises concerns about its long-term financial health and sustainability.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio7.20
- Financial Ratio4.00
- Profitability Ratio9.20
- Efficiency Ratio4.67
- Coverage Ratio2.00
- Solvency Ratio9.00
- Liquidity Ratio5.36
- Peer Assessment
- Management AssessmentWeak
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Quick Heal Technologies exhibits a mixed financial performance. The company demonstrates strong solvency due to its zero debt levels, but this is offset by poor coverage ratios. Growth is a mixed bag, with significant revenue and asset declines balanced by strong operating profit, EPS, and net income growth. Profitability metrics, such as gross profit margin, ROCE, ROE, operating margin, and net margin, are very strong, yet efficiency is significantly hampered by poor asset and capital turnover. Liquidity is also a concern, with low current, cash, and operating cash flow ratios. The IT sector's competitive landscape requires constant innovation and adaptation, and Quick Heal's ability to balance growth with efficiency and liquidity will be critical for its future success. The company's poor performance in some areas raises concerns about its long-term financial health and sustainability.
Overall Valuation Score
P/E RATIO (TTM)
6200.67
Industry Median
16.66
Small Cap Median
16.08
P/E RATIO
200.02
P/B RATIO
2.27
Industry Median
1.91
Small Cap Median
1.90
P/S RATIO
3.60
Industry Median
2.36
Small Cap Median
2.26
Others
PEG RATIO
-4.17
EV/EBITDA RATIO
70.52
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹186.02 as on Jun 15, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quick Heal Technologies exhibits a mixed growth performance. While the company has experienced declines in revenue and assets, it has demonstrated strong growth in operating profit, EPS, and net income. The weighted average calculation, which emphasizes recent performance, reflects this dichotomy. The company's ability to sustain profitability despite revenue declines is a positive sign, but addressing the revenue and asset growth challenges is crucial for long-term success.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 2.7 | -18.71 | 5.04 | -4.11 | -6.79 |
| Operating Profit Growth Rate | -24.11 | -98.13 | 800 | -138.89 | 314.29 |
| Earnings Per Share (EPS) Growth | -13.93 | -91.56 | 274.38 | -79.47 | -316.13 |
| Asset Growth Rate | -13.42 | -31.15 | 4.06 | 2.34 | 4.19 |
| Net Income Growth Rate | -22.43 | -92.77 | 300 | -79.17 | -320 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial health of the company, as reflected by its financial ratios, presents a mixed picture. While capital expenditures are managed well, earnings per share and book value per share are low, indicating potential challenges in profitability and shareholder value. The weighted average calculation, which emphasizes recent performance, underscores the need for improved earnings and asset management to enhance overall financial health. The company is distributing low dividend per share.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 13.79 | 0 | 4.07 | 0.56 | -2.04 |
| Cash Earnings Per Share (Cash EPS) | 17.24 | 4.15 | 6.85 | 3.33 | 0.56 |
| Book Value Per Share | 108.28 | 79.25 | 80.93 | 81.67 | 80.74 |
| Dividend Per Share (DPS) | 4.45 | 2.5 | 2.99 | 0 | 0 |
| Capital Expenditures (CapEx) | 2 | 1 | 7 | 14 | 9 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Quick Heal Technologies demonstrates strong profitability. High gross profit margin, return on capital employed, return on equity, operating margin, and net margin indicate efficient operations and effective cost management. The weighted average calculation, which emphasizes recent performance, supports this positive assessment. However, the low return on assets suggests that the company could improve its asset utilization to generate higher profits.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.32 | -5.04 | 1.71 | -7.14 | -16.48 |
| Return on Capital Employed (ROCE) | 15 | 0 | 6 | 0 | -5 |
| Return on Equity (ROE) | 13.22 | 1.43 | 5.49 | 1.13 | -2.52 |
| Return on Assets (ROA) | 14.94 | 0.41 | 3.51 | -1.33 | -5.3 |
| Operating Margin | 31.29 | 0.72 | 6.16 | -2.5 | -11.11 |
| Net Margin | 24.27 | 2.16 | 8.22 | 1.79 | -4.21 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency in utilizing its assets presents a mixed picture. While inventory management is strong, as indicated by the high Inventory Turnover Ratio and low Days Sales in Inventory Ratio, fixed asset and capital turnover are areas of concern. The weighted average calculation, which emphasizes recent performance, underscores the need for improved asset utilization to enhance overall efficiency. The current Receivable days are high, which is a concern.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.5 | 2.24 | 2.5 | 2.35 | 2.14 |
| Inventory Turnover Ratio | 63 | 64.89 | 82 | 119.6 | 121.6 |
| Receivables Turnover Ratio | 2.12 | 1.88 | 2.29 | 1.87 | 1.71 |
| Days Sales in Inventory Ratio | 5.79 | 5.62 | 4.45 | 3.05 | 3 |
| Receivable Days | 172.17 | 194.15 | 159.39 | 195.19 | 213.45 |
| Capital Turnover Ratio | 0.54 | 0.66 | 0.67 | 0.63 | 0.6 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's coverage ratios raise significant concerns about its ability to meet its financial obligations. Both the interest coverage ratio and the equity dividend coverage ratio are low, indicating potential difficulties in covering interest expenses and dividend payments. The weighted average calculation, which emphasizes recent performance, underscores the need for improved earnings and cash flow to enhance coverage capabilities.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | N/A | N/A | N/A | N/A | N/A |
| Equity Dividend Coverage Ratio | 3.23 | 0.48 | 1.52 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
Quick Heal Technologies demonstrates strong solvency. The absence of debt, as indicated by the debt ratio and debt-to-equity ratio, provides financial stability and flexibility. A high equity ratio further strengthens the company's financial position. However, the company's equity ratio has decreased significantly in the recent time. Overall, the company's solvency position is a notable strength, providing a solid foundation for future growth and stability.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 | 0 | 0 |
| Debt to Equity Ratio | 0 | 0 | 0 | 0 | 0 |
| Equity Ratio | 1 | 1 | 1 | 1 | 1 |
| Debt To Asset Ratio | 0 | 0 | 0 | 0 | 0 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position indicates some challenges in meeting its short-term obligations. While the quick ratio suggests an ability to cover immediate liabilities, the current and cash ratios point to potential difficulties. The weighted average calculation, emphasizing recent performance, highlights these concerns. The operating cash flow ratio further underscores the need for better cash management to ensure smooth operations. A positive aspect is the quick ratio is good it is better than the current, cash and operation cash flow ratios.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 2.97 | 2.31 | 2.67 | 2.72 | 1.93 |
| Quick Ratio | 2.91 | 2.26 | 2.63 | 2.7 | 1.9 |
| Cash Ratio | 0.72 | 0.16 | 0.5 | 0.25 | 0.12 |
| Operating Cash Flow Ratio | 0.91 | 0.42 | 0.24 | -0.27 | 0.14 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Innovana Thinklabs Ltd | 7.83 | 17.12 | Undervalued | 46.00 | 15.50 | 37.00 |
| 2 | Quick Heal Technologies Ltd | 6.87 | 200.02 | Neutral | -29.00 | -1.92 | -11.00 |
| 3 | Megasoft Ltd | 5.55 | -129.32 | Neutral | -10.00 | 1.15 | -30.00 |
| 4 | Subex Ltd | 3.03 | -19.59 | Neutral | 26.00 | 0.10 | 29.00 |
Quick Heal Technologies' management effectiveness is weak due to declining profit growth, significant drops in operating profit margin, and inconsistent sales growth. Debt management is under control, returns on capital and equity have deteriorated. Promoter holding is high, but declining institutional interest and poor financial performance raise concerns about management's strategic decisions and operational efficiency. The company's failure to translate revenue into sustained profit and returns suggests inefficiencies.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Promoter Holding | 71.82% | High promoter holding indicates continued confidence from key stakeholders. |
| CONS | Compounded Profit Growth (TTM) | -78% | Significant decline in profit growth raises concerns about long-term sustainability. |
| Operating Profit Margin (Mar 2025) | -2% | Deteriorating OPM indicates operational inefficiencies. |
Financial Performance & Growth
Quick Heal Technologies demonstrates concerning trends in financial performance and growth. Compounded Sales Growth is 0% over 5 and 10 years, and -6% over the last 3 years. The sales growth has been inconsistent, with a -4.19% decline in the most recent year (Mar 2025).
| Metric | Value |
|---|---|
| Compounded Sales Growth (10Y) | 0% |
| Compounded Sales Growth (5Y) | 0% |
| Compounded Sales Growth (3Y) | -6% |
| TTM Sales Growth | -4% |
| Recent YOY Sales Decline | -4.19% |
Compounded Profit Growth shows even more significant declines, with -41% over 5 years and -60% over 3 years, culminating in -78% TTM. The Operating Profit Margin (OPM) has deteriorated, moving from 35% (Mar 2014) to -2% (Mar 2025).
| Metric | Value |
|---|---|
| Compounded Profit Growth (10Y) | -21% |
| Compounded Profit Growth (5Y) | -41% |
| Compounded Profit Growth (3Y) | -60% |
| TTM Profit Growth | -78% |
Capital Efficiency & Returns
The capital efficiency and returns of Quick Heal Technologies present a concerning picture. The Return on Capital Employed (ROCE) has significantly declined over the years.
| Metric | Mar 2014 | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| ROCE % | 27% | 14% | 14% | 0% | 6% | 0% |
The Return on Equity (ROE) also shows a deteriorating trend over the last 10 years.
| Metric | 10 Years | 5 Years | 3 Years | Last Year |
|---|---|---|---|---|
| Return on Equity | 9% | 8% | 2% | 1% |
The Cash Conversion Cycle has fluctuated significantly, indicating potential inefficiencies in working capital management.
| Metric | Mar 2014 | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Cash Conversion Cycle | 104 | 118 | 144 | 161 | 165 | 218 |
Financial Health & Prudence
Quick Heal Technologies shows a mixed picture of financial health and prudence. Debt Management is under control as borrowings are negligible. The company has a zero Debt/Equity Ratio.
| Metric | Mar 2014 | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt/Equity Ratio | 0 | 0 | 0 | 0 | 0 | 0 |
Dividend Payout is inconsistent and even negative in Mar 2025.
| Metric | Mar 2014 | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Dividend Payout % | 78% | 33% | 35% | 207% | 66% | -0% |
Shareholding & Ownership Structure
The shareholding and ownership structure of Quick Heal Technologies reveals some mixed signals. Promoter Holding remains very high, indicating continued confidence from the company's founders and key stakeholders.
| Metric | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2025 |
|---|---|---|---|---|
| Promoters Holding % | 72.79% | 72.83% | 73.08% | 71.82% |
FII holding are fluctuating.
| Metric | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2025 |
|---|---|---|---|---|
| FIIs % | 8.56% | 2.21% | 2.04% | 2.03% |
DII Holding are very low.
| Metric | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2025 |
|---|---|---|---|---|
| DIIs % | 0.87% | 0.13% | 0.00% | 2.63% |
The risk assessment for Quick Heal Technologies indicates moderate concerns due to segment performance volatility and declining profitability, pointing to operational and strategic challenges. The company's high debtor days and cash conversion cycle also suggest risks in working capital management.
Segment performance volatility
The quarterly results show volatility in both sales and profit growth. The YOY Sales Growth % fluctuates significantly, ranging from -52.48% in Mar 2023 to 62.40% in Mar 2024. Similarly, YOY Profit Growth % demonstrates extreme variability, from -7,189% in Jun 2023 to 311% in Mar 2024. This indicates a lack of consistent performance across segments or operational activities.
Foreign exchange or interest rate exposure
The company's interest expenses are negligible, suggesting limited exposure to interest rate fluctuations. There is no significant impact from interest.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe